A facilitatory role of vasopressin in hypoxia/hypoglycemia-induced impairment of dopamine release from rat striatal slices

Mayumi Ochi, Schuichi Koizumi, Shigenobu Shibata, Shigenori Watanabe

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The excitatory amino acid, glutamate plays a crucial role in the pathogenesis of brain damage caused by anoxia and/or hypoglycemia. Although vasopressin (VP) also acts as an excitatory transmitter in the CNS, little is known about its effect on hypoxic and/or ischemic brain damage. In this study, we investigated the effect of arginine vasopressin (AVP) on hypoxia/hypoglycemia-induced impairment of dopamine release from striatal slices. Striatal slices were incubated in hypoxia-/hypoglycemia-inducing medium with or without AVP (0.01-1.0 μM) for 20 min. After 1-3 h of washout in normal medium, high K+-evoked dopamine release from the slices were examined. Hypoxia/hypoglycemia-induced decrease of striatal dopamine release was reversed by the removal of Ca2+ in the medium, but not by VP1- or VP2-receptor antagonist. In contrast, AVP potentiated the hypoxia/hypoglycemia-induced decrease of dopamine release in the striatum. This AVP-induced deterioration of the striatal response was antagonized by VP2 receptor antagonist, but not by VP1 receptor antagonist. The present results suggest that AVP may play a facilitatory role in hypoxia/hypoglycemia-induced dopamine release deficit mediated through the activation of VP2 receptor.

Original languageEnglish
Pages (from-to)91-96
Number of pages6
JournalBrain Research
Volume633
Issue number1-2
DOIs
Publication statusPublished - 1994 Jan 7
Externally publishedYes

Fingerprint

Corpus Striatum
Vasopressins
Hypoglycemia
Arginine Vasopressin
Dopamine
Excitatory Amino Acids
Brain
Hypoxia
Glutamic Acid

Keywords

  • Brain slice
  • Dopamine release
  • Hypoxia/hypoglycemia
  • Ischemia
  • Striatum
  • Vasopressin

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

A facilitatory role of vasopressin in hypoxia/hypoglycemia-induced impairment of dopamine release from rat striatal slices. / Ochi, Mayumi; Koizumi, Schuichi; Shibata, Shigenobu; Watanabe, Shigenori.

In: Brain Research, Vol. 633, No. 1-2, 07.01.1994, p. 91-96.

Research output: Contribution to journalArticle

@article{26472946dad248be8d75508b9caf7658,
title = "A facilitatory role of vasopressin in hypoxia/hypoglycemia-induced impairment of dopamine release from rat striatal slices",
abstract = "The excitatory amino acid, glutamate plays a crucial role in the pathogenesis of brain damage caused by anoxia and/or hypoglycemia. Although vasopressin (VP) also acts as an excitatory transmitter in the CNS, little is known about its effect on hypoxic and/or ischemic brain damage. In this study, we investigated the effect of arginine vasopressin (AVP) on hypoxia/hypoglycemia-induced impairment of dopamine release from striatal slices. Striatal slices were incubated in hypoxia-/hypoglycemia-inducing medium with or without AVP (0.01-1.0 μM) for 20 min. After 1-3 h of washout in normal medium, high K+-evoked dopamine release from the slices were examined. Hypoxia/hypoglycemia-induced decrease of striatal dopamine release was reversed by the removal of Ca2+ in the medium, but not by VP1- or VP2-receptor antagonist. In contrast, AVP potentiated the hypoxia/hypoglycemia-induced decrease of dopamine release in the striatum. This AVP-induced deterioration of the striatal response was antagonized by VP2 receptor antagonist, but not by VP1 receptor antagonist. The present results suggest that AVP may play a facilitatory role in hypoxia/hypoglycemia-induced dopamine release deficit mediated through the activation of VP2 receptor.",
keywords = "Brain slice, Dopamine release, Hypoxia/hypoglycemia, Ischemia, Striatum, Vasopressin",
author = "Mayumi Ochi and Schuichi Koizumi and Shigenobu Shibata and Shigenori Watanabe",
year = "1994",
month = "1",
day = "7",
doi = "10.1016/0006-8993(94)91526-1",
language = "English",
volume = "633",
pages = "91--96",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A facilitatory role of vasopressin in hypoxia/hypoglycemia-induced impairment of dopamine release from rat striatal slices

AU - Ochi, Mayumi

AU - Koizumi, Schuichi

AU - Shibata, Shigenobu

AU - Watanabe, Shigenori

PY - 1994/1/7

Y1 - 1994/1/7

N2 - The excitatory amino acid, glutamate plays a crucial role in the pathogenesis of brain damage caused by anoxia and/or hypoglycemia. Although vasopressin (VP) also acts as an excitatory transmitter in the CNS, little is known about its effect on hypoxic and/or ischemic brain damage. In this study, we investigated the effect of arginine vasopressin (AVP) on hypoxia/hypoglycemia-induced impairment of dopamine release from striatal slices. Striatal slices were incubated in hypoxia-/hypoglycemia-inducing medium with or without AVP (0.01-1.0 μM) for 20 min. After 1-3 h of washout in normal medium, high K+-evoked dopamine release from the slices were examined. Hypoxia/hypoglycemia-induced decrease of striatal dopamine release was reversed by the removal of Ca2+ in the medium, but not by VP1- or VP2-receptor antagonist. In contrast, AVP potentiated the hypoxia/hypoglycemia-induced decrease of dopamine release in the striatum. This AVP-induced deterioration of the striatal response was antagonized by VP2 receptor antagonist, but not by VP1 receptor antagonist. The present results suggest that AVP may play a facilitatory role in hypoxia/hypoglycemia-induced dopamine release deficit mediated through the activation of VP2 receptor.

AB - The excitatory amino acid, glutamate plays a crucial role in the pathogenesis of brain damage caused by anoxia and/or hypoglycemia. Although vasopressin (VP) also acts as an excitatory transmitter in the CNS, little is known about its effect on hypoxic and/or ischemic brain damage. In this study, we investigated the effect of arginine vasopressin (AVP) on hypoxia/hypoglycemia-induced impairment of dopamine release from striatal slices. Striatal slices were incubated in hypoxia-/hypoglycemia-inducing medium with or without AVP (0.01-1.0 μM) for 20 min. After 1-3 h of washout in normal medium, high K+-evoked dopamine release from the slices were examined. Hypoxia/hypoglycemia-induced decrease of striatal dopamine release was reversed by the removal of Ca2+ in the medium, but not by VP1- or VP2-receptor antagonist. In contrast, AVP potentiated the hypoxia/hypoglycemia-induced decrease of dopamine release in the striatum. This AVP-induced deterioration of the striatal response was antagonized by VP2 receptor antagonist, but not by VP1 receptor antagonist. The present results suggest that AVP may play a facilitatory role in hypoxia/hypoglycemia-induced dopamine release deficit mediated through the activation of VP2 receptor.

KW - Brain slice

KW - Dopamine release

KW - Hypoxia/hypoglycemia

KW - Ischemia

KW - Striatum

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0028069327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028069327&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)91526-1

DO - 10.1016/0006-8993(94)91526-1

M3 - Article

VL - 633

SP - 91

EP - 96

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -